Chris Benko is the CEO and co-founder of Koneksa Health, the leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research. Learn more at

Prior to founding Koneksa, Chris was a vice president in Merck’s corporate strategy office, working with its Global Health Innovation venture capital fund. He began his career at Merck in 1995 and progressed through roles in information technology as well as talent and organizational development, working in R&D, commercial, and at the corporate level as vice president for global talent management.

© 2024 BioFutureTM. All Rights Reserved

Produced by